These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
298 related items for PubMed ID: 30938057
1. Diagnostic value of serum high-mobility group box-1 in pediatric systemic lupus erythematosus. Hossny E, El-Ghoneimy D, Soliman DA, Ashour A. Int J Rheum Dis; 2019 Aug; 22(8):1402-1409. PubMed ID: 30938057 [Abstract] [Full Text] [Related]
2. Novel biomarkers for the assessment of paediatric systemic lupus erythematosus nephritis. Koutsonikoli A, Trachana M, Farmaki E, Tzimouli V, Pratsidou-Gertsi P, Printza N, Garyphallos A, Galanopoulou V, Kanakoudi-Tsakalidou F, Papachristou F. Clin Exp Immunol; 2017 Apr; 188(1):79-85. PubMed ID: 27936517 [Abstract] [Full Text] [Related]
3. High mobility group box protein 1 (HMGB1) serum and urinary levels and gene polymorphism in Egyptian patients with systemic lupus erythematosus: A possible relation to lupus nephritis. Hisham FA, Tharwat S, Samra NE, Mostafa N, Nassar MK, El-Desoky MM. Lupus; 2022 Dec; 31(14):1777-1785. PubMed ID: 36214106 [Abstract] [Full Text] [Related]
4. High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus. Abdulahad DA, Westra J, Bijzet J, Limburg PC, Kallenberg CG, Bijl M. Arthritis Res Ther; 2011 May 06; 13(3):R71. PubMed ID: 21548924 [Abstract] [Full Text] [Related]
5. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus. Kwon OC, Ghang B, Lee EJ, Hong S, Lee CK, Yoo B, Kim S, Kim YG. Int J Rheum Dis; 2019 Jul 06; 22(7):1305-1311. PubMed ID: 30941928 [Abstract] [Full Text] [Related]
6. Neutrophil extracellular traps are a source of extracellular HMGB1 in lupus nephritis: associations with clinical and histopathological features. Whittall-García LP, Torres-Ruiz J, Zentella-Dehesa A, Tapia-Rodríguez M, Alcocer-Varela J, Mendez-Huerta N, Gómez-Martín D. Lupus; 2019 Nov 06; 28(13):1549-1557. PubMed ID: 31619143 [Abstract] [Full Text] [Related]
7. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis. Adhya Z, El Anbari M, Anwar S, Mortimer A, Marr N, Karim MY. Lupus; 2019 May 06; 28(6):713-721. PubMed ID: 31046570 [Abstract] [Full Text] [Related]
8. Simultaneous changes in serum HMGB1 and IFN-α levels and in LAIR-1 expression on plasmatoid dendritic cells of patients with juvenile SLE. New therapeutic options? Kanakoudi-Tsakalidou F, Farmaki E, Tzimouli V, Taparkou A, Paterakis G, Trachana M, Pratsidou-Gertsi P, Nalbanti P, Papachristou F. Lupus; 2014 Mar 06; 23(3):305-12. PubMed ID: 24399813 [Abstract] [Full Text] [Related]
9. Autoantibodies to box A of high mobility group box 1 in systemic lupus erythematosus. Schaper F, de Leeuw K, Horst G, Maas F, Bootsma H, Heeringa P, Limburg PC, Westra J. Clin Exp Immunol; 2017 Jun 06; 188(3):412-419. PubMed ID: 28245520 [Abstract] [Full Text] [Related]
10. Urine levels of HMGB1 in Systemic Lupus Erythematosus patients with and without renal manifestations. Abdulahad DA, Westra J, Bijzet J, Dolff S, van Dijk MC, Limburg PC, Kallenberg CG, Bijl M. Arthritis Res Ther; 2012 Aug 14; 14(4):R184. PubMed ID: 22892043 [Abstract] [Full Text] [Related]
11. The behavior of neutrophil extracellular traps and NADPH oxidative activity in pediatric systemic lupus erythematosus: relation to disease activity and lupus nephritis. El-Ghoneimy DH, Hesham M, Hasan R, Tarif M, Gouda S. Clin Rheumatol; 2019 Sep 14; 38(9):2585-2593. PubMed ID: 31030361 [Abstract] [Full Text] [Related]
12. Association of anti-CLIC2 and anti-HMGB1 autoantibodies with higher disease activity in systemic lupus erythematosus patients. Syahidatulamali CS, Wan Syamimee WG, Azwany YN, Wong KK, Che Maraina CH. J Postgrad Med; 2017 Sep 14; 63(4):257-261. PubMed ID: 28862243 [Abstract] [Full Text] [Related]
13. The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus. Bobek D, Grčević D, Kovačić N, Lukić IK, Jelušić M. Pediatr Rheumatol Online J; 2014 Sep 14; 12():50. PubMed ID: 25516724 [Abstract] [Full Text] [Related]
14. Serum thiols as a biomarker of disease activity in lupus nephritis. Lalwani P, de Souza GK, de Lima DS, Passos LF, Boechat AL, Lima ES. PLoS One; 2015 Sep 14; 10(3):e0119947. PubMed ID: 25799079 [Abstract] [Full Text] [Related]
15. Serum IP-10 is useful for identifying renal and overall disease activity in pediatric systemic lupus erythematosus. Zhang CX, Cai L, Shao K, Wu J, Zhou W, Cao LF, Chen TX. Pediatr Nephrol; 2018 May 14; 33(5):837-845. PubMed ID: 29264699 [Abstract] [Full Text] [Related]
16. Serum uric acid as a predictor for nephritis in Egyptian patients with systemic lupus erythematosus. Hafez EA, Hassan SAE, Teama MAM, Badr FM. Lupus; 2021 Mar 14; 30(3):378-384. PubMed ID: 33323012 [Abstract] [Full Text] [Related]
17. Urine S100 proteins as potential biomarkers of lupus nephritis activity. Turnier JL, Fall N, Thornton S, Witte D, Bennett MR, Appenzeller S, Klein-Gitelman MS, Grom AA, Brunner HI. Arthritis Res Ther; 2017 Oct 24; 19(1):242. PubMed ID: 29065913 [Abstract] [Full Text] [Related]
18. High titer anti-basement membrane antibodies in a subset of patients with pediatric systemic lupus erythematosus. Orjuela A, Suwanichkul A, Canter D, Minard CG, Devaraj S, Hicks MJ, Muscal E, Wenderfer SE. Am J Nephrol; 2015 Oct 24; 41(3):241-7. PubMed ID: 25926050 [Abstract] [Full Text] [Related]
19. Measuring serum levels of high-mobility group box 1 by enzyme-linked immunosorbent assay does not identify bacterial infections in patients with systemic lupus erythematosus. Tang KT, Hsieh TY, Chen YM, Hsieh CW, Chen YH, Chen DY. Lupus; 2014 Aug 24; 23(9):926-34. PubMed ID: 24704776 [Abstract] [Full Text] [Related]
20. Autoantigen microarrays reveal autoantibodies associated with proliferative nephritis and active disease in pediatric systemic lupus erythematosus. Haddon DJ, Diep VK, Price JV, Limb C, Utz PJ, Balboni I. Arthritis Res Ther; 2015 Jun 17; 17(1):162. PubMed ID: 26081107 [Abstract] [Full Text] [Related] Page: [Next] [New Search]